Live feed of FDA Import Alert 66-40, OFAC SDN, and other counterparty sanctions hitting suppliers. Pre-RFQ screen for active enforcement exposure.
Sixty-six live counterparty sanctions events sit on the feed: 65 FDA Import Alert 66-40 (Detention Without Physical Examination) listings, plus one OFAC SDN designation. The cohort spans India, China, Mexico, and South Korea. Wizcure Pharmaa and Flowchem Pharma were the most recent Indian additions; Xiamen Kang Zhongyuan and Hangzhou Yiqi Biotechnology were the most recent Chinese additions. A buyer running the feed pre-RFQ catches exposure that a quarterly review would miss.
Portfolio-wide, supplier-specific, or geography-specific. The AI agent subscribes to the live sanctions feed and surfaces hits matching the filter.
Each sanctions hit is joined to supplier plant data, recent shipments to the buyer's region, and any overlap with the buyer's existing supplier base.
Citation-anchored brief with the event stream, supplier overlap chips, and a one-click alert subscription on new listings.
Import Alert 66-40 publishes weekly. A quarterly review misses the window where a supplier transitions from clean to listed. The feed catches it in days.
Running the feed against the shortlist before issuing an RFQ removes listed suppliers from the cohort upfront. Cheaper than re-running qualification after a hit.
Sanctions load is unevenly distributed across countries. The feed surfaces the per-country baseline, so a buyer in a heavily-sanctioned region screens harder.
Counterparty linkage is summarised. PharmaDB does not surface named buyer-to-seller transactions; the sanctions event itself is public record.
A real chat thread in PharmaDB. Type a question, the AI agent runs the tools, the answer lands as a saveable note.
pharmagraph_query Active counterparty sanctions, by region · most recent 26 listings in the 12-month window.
Counterparty sanctions are the hardest-edged enforcement signal. PharmaDB ingests FDA Import Alert 66-40 (DWPE), OFAC SDN, and major-jurisdiction enforcement events and surfaces them as a live feed against the supplier base. The view rests on company_sanctions joined to global_companies. Refresh cadence is weekly.
Detention Without Physical Examination (DWPE) for drugs that appear to be in violation of CGMP. When a supplier is added to 66-40, FDA holds incoming shipments at the border without examination. The supplier must demonstrate compliance to be removed.
Within a week. FDA Import Alert publications are pulled weekly. OFAC SDN updates are pulled weekly. New listings carry the publication date on the feed.
Listed suppliers can still supply other markets (EU, LatAm, MENA). A buyer running multi-market procurement needs the geographic-specific view; a listing for US import does not automatically disqualify a supplier for EU or APAC supply. The chip surfaces the listing's scope.
The headline is FDA Import Alert and OFAC SDN. EU regulator actions (EMA GMP non-compliance, MHRA suspension) live in the broader `compliance_events` feed and surface via the Warning Letter Monitor page. The companion view stitches both surfaces together.
An active sanctions listing is an absolute disqualifier on the default scorecard. A listed supplier never ranks; the chip surfaces unmissably. Buyers can opt to include listed suppliers in historical analysis but not in the live shortlist.
Weekly. FDA Import Alert and OFAC SDN both publish weekly. The catalog row carries an as-of timestamp on every result page.
Bring the molecule, the lane, or the supplier you're sourcing this week. The AI agent runs it on PharmaDB in 30 minutes. You keep the brief.